Literature DB >> 16677417

Reaction to the threat of influenza pandemic: the mass media and the public.

Matthew E Falagas, Ismene J Kiriaze.   

Abstract

Entities:  

Mesh:

Year:  2006        PMID: 16677417      PMCID: PMC1550896          DOI: 10.1186/cc4910

Source DB:  PubMed          Journal:  Crit Care        ISSN: 1364-8535            Impact factor:   9.097


× No keyword cloud information.

During the past few months we witnessed two phases in the reaction of the public in Greece to the threat of an influenza pandemic. Initially, during October 2005, practically all mass media in the country devoted extensive time to the coverage of various aspects of the outbreak of avian influenza. An overflow of information from the media targeted the general public who did not have prior knowledge of this type of influenza and who were not aware of the possibility of such a pandemic. The psychological impact to the public that was caused by the media was intense. The reaction of the public for self-preservation under this psychological condition was to rely on the immediate use of influenza vaccine. As a result, more than one million influenza vaccine doses were sold, mainly over the counter; people were vaccinated without risk assessment or without priority being given to those more vulnerable to influenza. This led to a situation where a considerable number of people who are in need of the influenza vaccine, including the elderly and immuno-compromised patients, are deprived of the availability of the vaccine. Surprisingly, after the overwhelming coverage of the possibility of an influenza pandemic from the media during October 2005, the follow-up on the issue was almost complete silence during November and December 2005 (this manuscript was written prior to the occurrence of human cases of avian influenza in Turkey in January 2006). The alarmed state was replaced by a silence of equivalent intensity and the public was left with the impression that the possibility of influenza pandemic crisis was over. This phenomenon, namely the initial over-reaction and subsequently the under-reaction of the public, was probably not unique to Greece; instead, we believe that a similar sequence of events related to the threat of influenza pandemic occurred in many other countries. Important conclusions may be derived from this experience that may become a classic example for the mass media to avoid in the coverage of public health risks [1,2]. We believe that public health agencies should have operational plans towards the delivery of information to the public that are promptly implemented. They should make use of all types of mass media in a timely manner, before the media presents potentially unfiltered information to the public regarding a health-related risk such as the influenza pandemic. Effective risk communication is a priority early in an outbreak. Both the mass media and public health authorities have the responsibility to deliver correct information to the public. The fear-based approach and over-reaction towards a potential influenza pandemic may be hazardous to the general public, because it encourages solutions that inhibit the ability to properly respond to a potential pandemic.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

Both authors contributed to the writing of the manuscript and approved its final version.
  2 in total

1.  Preparing for an influenza pandemic: ethical issues.

Authors:  Jaro Kotalik
Journal:  Bioethics       Date:  2005-08       Impact factor: 1.898

2.  Public communication, risk perception, and the viability of preventive vaccination against communicable diseases.

Authors:  Thomas May
Journal:  Bioethics       Date:  2005-08       Impact factor: 1.898

  2 in total
  9 in total

1.  A comparison of the completeness and timeliness of automated electronic laboratory reporting and spontaneous reporting of notifiable conditions.

Authors:  J Marc Overhage; Shaun Grannis; Clement J McDonald
Journal:  Am J Public Health       Date:  2008-01-02       Impact factor: 9.308

2.  Including the public in pandemic planning: a deliberative approach.

Authors:  Annette J Braunack-Mayer; Jackie M Street; Wendy A Rogers; Rodney Givney; John R Moss; Janet E Hiller
Journal:  BMC Public Health       Date:  2010-08-19       Impact factor: 3.295

3.  Influenza pandemic: perception of risk and individual precautions in a general population. Cross sectional study.

Authors:  Ivar S Kristiansen; Peder A Halvorsen; Dorte Gyrd-Hansen
Journal:  BMC Public Health       Date:  2007-04-02       Impact factor: 3.295

4.  A Preliminary Evaluation of the Public Risk Perception Related to the COVID-19 Health Emergency in Italy.

Authors:  Giulia Motta Zanin; Eleonora Gentile; Alessandro Parisi; Danilo Spasiano
Journal:  Int J Environ Res Public Health       Date:  2020-04-27       Impact factor: 3.390

5.  Adaptation and psychometric evaluation of Hungarian version of the Fear of COVID-19 Scale.

Authors:  Mona Stankovic; László Papp; Boglárka Nyúl; László Ivánkovits; Zoltán Pető; Annamária Töreki
Journal:  PLoS One       Date:  2021-12-29       Impact factor: 3.240

6.  COVID-19 and the Elderly's Mental Illness: The Role of Risk Perception, Social Isolation, Loneliness and Ageism.

Authors:  Anna Rosa Donizzetti; Martine Lagacé
Journal:  Int J Environ Res Public Health       Date:  2022-04-08       Impact factor: 4.614

7.  Validation of the Canadian French version of the fear of COVID-19 scale in the general population of Quebec.

Authors:  Randa Attieh; Kouamé Koffi; Moustapha Touré; Érica Parr-Labbé; Amir H Pakpour; Thomas G Poder
Journal:  Brain Behav       Date:  2022-03-30       Impact factor: 3.405

8.  COVID-19 surveillance in Israeli press: Spatiality, mobility, and control.

Authors:  Aya Yadlin; Avi Marciano
Journal:  Mob Media Commun       Date:  2022-09

Review 9.  Psychosocial consequences of infectious diseases.

Authors:  G Pappas; I J Kiriaze; P Giannakis; M E Falagas
Journal:  Clin Microbiol Infect       Date:  2009-08       Impact factor: 8.067

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.